Company: IMNN
Filing Date: 2025-12-31
Form Type: 424B5
Source: 0001493152-25-029712
Chunk: 40

Company: Imunon, Inc.
Filing Date: 2025-12-31
Form: 424B5
Chunk 40
---
 our common stock, preferred stock and/or debt securities in one or more series together with other securities or separately, as described in the applicable prospectus supplement. Below is a description of certain general terms and provisions of the warrants that we may offer. Particular terms of the warrants will be described in the warrant agreements and the prospectus supplement relating to the warrants.

The applicable prospectus supplement will contain, where applicable, the following terms of and other information relating to the warrants:

| ● | the                                                                                               
 specific designation and aggregate number of, and the price at which we will issue, the warrants; |

| ● | the                                                                                        
 currency or currency units in which the offering price, if any, and the exercise price are 
 payable;                                                                                   |

| ● | the                                                                                        
 designation, amount and terms of the securities purchasable upon exercise of the warrants; |

| ● | if                                                                                        
 applicable, the exercise price for shares of our common stock and the number of shares of 
 common stock to be received upon exercise of the warrants;                                |

| ● | if                                                                                              
 applicable, the exercise price for shares of our preferred stock, the number of shares of       
 preferred stock to be received upon exercise, and a description of that series of our preferred 
 stock;                                                                                          |

| ● | if                                                                                       
 applicable, the exercise price for our debt securities, the amount of debt securities to 
 be received upon exercise, and a description of that series of debt securities;          |

| ● | the                                                                                          
 date on which the right to exercise the warrants will begin and the date on which that right 
 will expire or, if you may not continuously exercise the warrants throughout that period,    
 the specific date or dates on which you may exercise the warrants;                           |

| ● | whether                                                                                          
 the warrants will be issued in fully registered form or bearer form, in defmitive or global      
 form or in any combination of these forms, although, in any case, the form of a warrant included 
 in a unit will correspond to the form of the unit and of any security included in that unit;     |

| ● | any                                                       
 applicable material U.S. federal income tax consequences; |

| ● | the                                                                                        
 identity of the warrant agent for the warrants and of any other depositaries, execution or 
 paying agents, transfer agents, registrars or other agents;                                |

| ● | the                                                                                      
 proposed listing, if any, of the warrants or any securities purchasable upon exercise of 
 the warrants on any securities exchange